Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells.
Yan, Bin
Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells. [electronic resource] - Bioscience reports Oct 2017
Publication Type: Journal Article
1573-4935
10.1042/BSR20170685 doi
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
Glyburide--pharmacology
Hep G2 Cells
Humans
Hypoglycemic Agents--pharmacology
Liver Neoplasms--drug therapy
MAP Kinase Signaling System--drug effects
Reactive Oxygen Species--metabolism
Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells. [electronic resource] - Bioscience reports Oct 2017
Publication Type: Journal Article
1573-4935
10.1042/BSR20170685 doi
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
Glyburide--pharmacology
Hep G2 Cells
Humans
Hypoglycemic Agents--pharmacology
Liver Neoplasms--drug therapy
MAP Kinase Signaling System--drug effects
Reactive Oxygen Species--metabolism